Quick Takes Off-label use of direct oral anticoagulants (DOACs) in severe renal insufficiency can pose an elevated risk of pericardial bleeding. In patients at high-risk of bleeding, the available laboratory assays can potentially aid in personalizing antithrombotic therapy. In life-threatening hemopericardium due to DOAC use, specific DOAC reversal agents…
ACC President Cathie Biga, MSN, FACC launched her “Heart Talk with Cathie” presidential discussion live from MedAxiom’s CVTransforum in Atlanta. With the hel…
This assessment option, called the Collaborative Maintenance Pathway, will be available for cardiovascular disease starting in 2019, and it will integrate lifelong learning with assessment.
Debabrata Mukherjee, MD, FACC
In this week’s View, Dr. Eagle looks at a systematic review and meta-analysis of antibiotic prophylaxis and infective endocarditis incidence following invasive dental procedures. He…
Geoffrey D. Barnes, MD, MSc, FACC
Debabrata Mukherjee, MD, FACC
The ACC is leading the transformation of care by advocating for a quality driven health care system, provider stability, population health and the future of…
The U.S. Food and Drug Administration (FDA) announced on April 15 that Abbott/Thoratec Corp. is recalling the Heartmate II and Heartmate 3 Left Ventricular Assist…
∗Address for correspondence: Ms Cathleen Biga, American Coll ege of Cardiology, 2400 N Street, NW, Washington, DC 20037, USA. E-mail: E-mail Address: [email protected] As…
